Sensei Biotherapeutics, Inc. (SNSE) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SNSE currently has 1.3M outstanding shares. with significant dilution risk as 43.4M authorized shares could dilute existing holders by 3350.2%. The company has minimally diluted shareholders by 3.19% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Jun 02, 2026 |
S-3/A filing: This prospectus relates to the proposed resale of 24,868,028 shares of common stock by selling stockholders, including shares issuable upon conversion of Series B Preferred Stock and exercise of a warrant. |
1.3M | 43M |
| May 15, 2026 |
10-Q filing | 1.3M shares outstanding |
1.3M | 19M |
| Mar 30, 2026 |
10-K filing | 1.3M shares outstanding |
1.3M | 19M |
| May 06, 2025 |
10-Q filing | 25.2M shares outstanding |
25M | 19M |
| Mar 28, 2025 |
10-K filing | 25.1M shares outstanding |
25M | 19M |
| Nov 14, 2024 |
10-Q filing | 25.1M shares outstanding |
25M | 19M |
| Aug 06, 2024 |
10-Q filing | 25.1M shares outstanding |
25M | 19M |
| May 09, 2024 |
10-Q filing | 25.0M shares outstanding |
25M | 19M |
| Feb 29, 2024 |
10-K filing | 25.1M shares outstanding |
25M | 19M |
| Nov 07, 2023 |
10-Q filing | 25.5M shares outstanding |
26M | 19M |
| Aug 03, 2023 |
10-Q filing | 26.6M shares outstanding |
27M | 19M |
| May 09, 2023 |
10-Q filing | 30.9M shares outstanding |
31M | 19M |
| Mar 29, 2023 |
10-K filing | 30.7M shares outstanding |
31M | 19M |
| Nov 08, 2022 |
10-Q filing | 30.7M shares outstanding |
31M | 19M |
| Aug 09, 2022 |
10-Q filing | 30.7M shares outstanding |
31M | 19M |
| May 10, 2022 |
10-Q filing | 30.6M shares outstanding |
31M | 19M |
| Mar 15, 2022 |
S-3 filing: The filing is an S-3 form indicating that the company may offer and sell up to $150,000,000 of common stock, preferred stock, and debt securities in one or more offerings. A portion of common stock, up to $50,000,000 is being offered through an At-The-Market offering through Jefferies. |
31M | 19M |
| Mar 15, 2022 |
10-K filing | 30.7M shares outstanding |
31M | 19M |
| Nov 10, 2021 |
10-Q filing | 30.6M shares outstanding |
31M | 0 |
| Aug 11, 2021 |
10-Q filing | 30.6M shares outstanding |
31M | 0 |
| May 13, 2021 |
10-Q filing | 30.6M shares outstanding |
31M | 0 |
| Jan 15, 2021 |
S-1 filing: This is an S-1 filing for an IPO registration of common stock. It includes agreements on market stand-off and transfer restrictions. |
N/A | 0 |